Smoking remains one of the most important — and most neglected — modifiable risk factors in the management of type 2 diabetes (T2D). Despite strong evidence that quitting reduces cardiovascular…
University of Catania's CoEHAR continues to expand its scientific footprint in the field of metabolic diseases, organizing the 4th “Type 2 Diabetes in Internal Medicine Practice – Experience Sharings” meeting,…
For the first time since national records began, e-cigarette use has surpassed cigarette smoking in Great Britain. This milestone, highlighted in a new CoEHAR commentary published in the International Journal…
The relationship between e-cigarette use and oral health remains a topic of active scientific debate. While some studies have suggested potential risks, the underlying evidence is often fragmented and difficult…
The damage caused by smoking does not start with a heart attack. It begins much earlier, at the level of the blood vessels. When someone smokes, the chemicals produced by…
CoEHAR is proud to announce that Dr. Rossella Cannarella has been awarded one of the prestigious Tobacco Harm Reduction Scholarships (THRSP) — an international program supporting early-career researchers engaged in…
Oral cancer remains one of the most preventable yet persistent global health challenges. Tobacco smoking continues to be its most consistent and powerful risk factor, driven by decades of exposure…
The World Health Organization (WHO) has added cytisine to its Model List of Essential Medicines (EML), marking a major milestone for global tobacco control and smoking cessation. The decision formally…
For people living with diabetes, smoking represents much more than a harmful habit — it is a major driver of cardiovascular complications and long-term metabolic damage. Quitting is one of…
Medical systematic reviews sit at the top of the evidence hierarchy. They are meant to guide clinicians, policymakers, and patients by carefully summarizing what research truly shows. But what happens…
